NewsRx

Search our medical news database

Oncology Business Week

Susan Hasty, Publisher

Table of Contents . . . May 9th, 2004

Non-Subscriber - Summaries Only

Related Areas: Other Issues in Oncology Business Week | Other Publications

AnorMED, Inc. - NeoRx acquires cancer compound

AnorMED, Inc. - Oncology company licenses cancer compound to NeoRx

Bayer Pharmaceuticals Corp. - BAY 43-9006 receives FDA fast track designation

Digene Corp. - Study documents cost-effectiveness of HPV test in cervical cancer prevention

GlaxoSmithKline Pharmaceuticals - Proton magnetic resonance spectroscopy can monitor glioma response to treatment

Hybridon, Inc. - Phase I healthy volunteer trial of HYB2055 completed

Kosan Biosciences - AACR data indicate strong synergy of Hsp90 inhibitor, 17-AAG

Ligand Pharmaceuticals, Inc. - Company updates SPIRIT I and II pivotal studies of Targretin capsules

Ligand Pharmaceuticals, Inc. - Studies support Targretin's activity in NSCLC

Massachusetts Institute of Technology - Treatment based on radar research is in final stage of clinical testing

Matritech - NMP22 BladderChek reaches milestone

NeoPharm - Company selected to produce IL13-PE38QQR for phase III trial

Peregrine Pharmaceuticals - Pharmaceutical company presents data at cancer research meeting

Proxima Therapeutics, Inc. - New reimbursement codes announced for MammoSite balloon catheter

Technical University of Aachen - Role of mtDNA mutations in MDS-leukemia transition determined

Tokyo Medical & Dental University - BMP-2 modulates proliferation and differentiation of gastric cancer cells

AVI BioPharma, Inc. - Biotech company expands management team

Affymax, Inc. - VP of development, director of clinical development named at oncology firm

Aletheon Pharmaceuticals, Inc. - NeoRx sells Pretarget intellectual property, announces resignation of VP

Antigen Express - Generex reports advance in cancer immunotherapy

Cancer - Updated nausea and vomiting treatment guidelines offered to cancer patients

Cancer Detection - Study questions reliability of new colon cancer detection method

Cancer Treatment - 3M skin cancer treatment final FDA approval delayed

Cancer Treatment - Atlanta hospital opens new outpatient center with $2.5 million from AFLAC

Carnegie Mellon University - Spouse social control associated with poor health behavior in prostate cancer

Catholic Univ. of Korea, Seoul - HCCR-2 related to breast cancer development and p53 tumor suppressor regulation

Cedars-Sinai Comprehensive Cancer Center - Aromatase inhibitors may replace tamoxifen

Cheju National University - Eurya emarginata extracts inhibit leukemia cell growth via apoptosis induction

Chosun University, Dwangju - System L amino acid transporter rationale for oral cancer therapy

Cornell University - Age itself is not a factor in determining the management of lung cancer

Cornell University - PML tumor suppressor gene mutations indicate poor APL prognosis

Cytogen Corporation - Oncology company appoints senior VP of sales and marketing

East Carolina University - No race differences in breast cancer support group participation

Erasmus Medical Center, Rotterdam -  FGFR3 and P53 are often seen in bladder cancer

Free Univ. of Amsterdam - Million Women Study: Hormone replacement therapy increases breast cancer risk

Free University of Brussels - Dendritic cell tumoristatic and tumoricidal activities are distinct

GBF, Braunschweig - A novel assay quantifies vascular endothelial growth factor-C

Georges Pompidou European Hospital - Early anti-EBV cytotoxic immune response impaired in HIV patients

Graz University - Locoregional recurrence of malignant melanoma has various treatment options

Hokkaido University - Nedd 4 or ubiquitin ligase Nedd4 regulates human T-cell leukemia virus type 1

Hokkaido University - Oncogenesis from single base mutation in IRES of Epstein-Barr nuclear antigen 1

INSERM U412, Lyon - Lentiviral vectors can be re-engineered to optimize gene delivery

ImClone Systems Inc. - Company reports advancements in several pipeline programs at AACR meeting

Institut Gustave Roussy - Doxorubicin-streptozotocin useful for treating pancreatic carcinoma

Institute Gustave Roussy, Villejuif - Cancer patients prefer quality-of-life assessor EORTC QLQ-C30 over FACIT

Institute of Cancer Research, Surrey - Thyroglobulin polymorphic variation increases non-medullary thyroid cancer risk

Johns Hopkins University - Some patterns of alcohol intake are related to the risk of prostate cancer

Josephine Ford Cancer Center - Online tool estimates long-term chance of surviving cancer

Kagoshima University - Anterior mediastinal masses can be resected via figure-L mini-sternotomy

Kanazawa Medical University - Hepatitis C virus core protein intercepts p53 activity to halt apoptosis

Keio University - Researchers discuss future applications of sentinel node technology

Koo Fdn. Sun Yat Sen Cancer Center - Certain antitumor agents can suppress cutaneous radiation syndrome

Korea Advanced Inst. of Science & Technology - gONC increases conformational stability and toxicity for cancer cells

Laval University - Ptc acts as a tumor suppressor gene in bladder cancer

Lawrence Berkeley Laboratory - Malignant breast cancer cells revert to normal with manipulation

Legal Issues - Judge dismisses Magee Pap smear lawsuit

Legal Issues - Two new federal probes of Tenet hospitals launched

Leicester Royal Infirmary - British Asian cancer patients want better information

Leiden University - Extended lymph node dissection fails to increase survival

Leiden University - Sentinel node biopsy should be standardized

Ludwik Rydygier Medical Univ. - Familial melanoma syndrome increases risk of malignant neoplasms

M.D. Anderson Cancer Center - Researchers develop polarized reflectance spectroscopy for precancer detection

Mayo Clinic - Deficiency in alpha 1-antitrypsin increases risk of certain cancers

Medical Center, Haaglanden - Cognitive function can decline in patients with brain tumors

Medical Research Council, London - Prognostic model applied to superficial bladder cancer

Medical University Innsbruck - Test shows promise for identifying gene alteration indicating cancer

Medical University of Warsaw - Proteasome inhibition in colon cancer associates with increased VEGF levels

MethylGene, Inc. - Research shows evidence of synergy and molecular activity of MG98

Munster University Hospital - Digital oncology documentation system integration increases quality assurance

Nagoya University - P73 A4T14 genotype associated with cervical cancer risk

National Cancer Center, Tokyo - Local chemotherapy preserves eyeballs with vitreous seeding

National Defense Medical Center, Taiwan - Pre-emptive use of lamivudine prevents hepatitis B in breast cancer

National Taiwan University - CD30 mediates T-cell inhibition by Hodgkin Reed-Sternberg cells

National Taiwan University Hospital - Childhood hepatitis B e antigen seroconversion may be a risk for liver cancer

National Yang Ming Univ. - Notch1 gene involved in ATRA-modulated differentiation process in APL

New York Presbyterian Hospital - Inaccurate understanding perceives do-not-resuscitate as morally wrong

Northwestern Memorial Hospital - Treatment delivers radioactive isotope directly into the liver with embolization

Oregon Health & Science University - Self-doctoring among physicians has benefits, pitfalls

Peking Union Medical College - Genetic cancer alterations seen between ethnic populations

Personnel - The Susan G. Komen Breast Cancer Foundation names new board members

Ruhr University of Bochum - Lower leg perforator flaps are used for intraoral reconstruction

Shanghai Institutes for Biological Sciences - Metastasis-associated protein analysis indicates different metastasis roles

Spectrum Pharmaceuticals, Inc. - Phase II elsamitrucin trial launched for refractory non-Hodgkin lymphoma

St. Christopher's Hospice, London - Adequate analgesia is important for patients with advanced disease

Return to Top of Page

NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook